SI-BONE, Inc. (SIBN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about SI-BONE, Inc. (SIBN)
Company Performance

Current Price

as of Oct 16, 2024

$13.22

P/E Ratio

N/A

Market Cap

$551.2M

Description

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

Metrics

Overview

  • HQSanta Clara, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerSIBN
  • Price$13.22+0.61%

Trading Information

  • Market Cap$551.20M
  • Float88.07%
  • Average Daily Volume (1m)356,551
  • Average Daily Volume (3m)332,572
  • EPS-$1.00

Company

  • Revenue$150.71M
  • Rev Growth (1yr)20.01%
  • Net Income-$8.94M
  • Gross Margin79.00%
  • EBITDA Margin-22.73%
  • EBITDA-$9.09M
  • EV$422.71M
  • EV/Revenue2.80
  • P/EN/A
  • P/S3.62
  • P/B3.33